A novel method of adverse event detection can accurately identify venous thromboembolisms (VTEs) from narrative electronic health record data
Christian M. Rochefort(McGill University), David L. Buckeridge(McGill University), Aman Verma(McGill University), Todd C. Lee(McGill University Health Centre), Tewodros Eguale(Brigham and Women's Hospital)
Cited by 82
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
|The Lancet Infectious Diseases|2023|658
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2
|JAMA Internal Medicine|2021|327